ClinicalTrials.gov record
Pan Tumor Rollover Study
ClinicalTrials.gov ID: NCT03899155
Public ClinicalTrials.gov record NCT03899155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 6, 2026, 8:36 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies
Study identification
- NCT ID
- NCT03899155
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 1,500 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Drug
- Cabozantinib Drug
- Capecitabine Drug
- Daratumumab Drug
- Enzalutamide Drug
- Fluorouracil Drug
- Ipilimumab Drug
- Leucovorin Drug
- Nivolumab Drug
- Nivolumab + Relatlimab Drug
- Oxaliplatin Drug
- Pembrolizumab Drug
- Pemetrexed Drug
- Regorafinib Drug
- Relatlimab Drug
- Rucaparib Drug
- Sunitinib Drug
- Temozolomide Drug
- Trametinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 8, 2019
- Primary completion
- Aug 24, 2029
- Completion
- Aug 24, 2029
- Last update posted
- Mar 31, 2026
2019 – 2029
United States locations
- U.S. sites
- 59
- U.S. states
- 30
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0220 | Huntsville | Alabama | 35801 | Completed |
| University of Arizona College of Medicine | Tucson | Arizona | 85724 | Withdrawn |
| Innovative Clinical Research Institute | Lynwood | California | 90262 | Withdrawn |
| Local Institution | San Francisco | California | 94115 | Withdrawn |
| Local Institution - 0099 | San Francisco | California | 94143 | Completed |
| Local Institution - 0233 | Aurora | Colorado | 80045 | Completed |
| Local Institution - 0095 | New Haven | Connecticut | 06520 | Withdrawn |
| Local Institution - 0088 | Washington D.C. | District of Columbia | 20007-2113 | Completed |
| Florida Cancer Affiliates | Ocala | Florida | 34474 | Withdrawn |
| Local Institution | Orlando | Florida | 32806 | Withdrawn |
| Local Institution - 0024 | Tampa | Florida | 33612 | Completed |
| Local Institution - 0105 | Chicago | Illinois | 60637 | Completed |
| Local Institution | Maywood | Illinois | 60153 | Withdrawn |
| Local Institution - 0279 | Park Ridge | Illinois | 60068 | Completed |
| Local Institution - 0186 | Westwood | Kansas | 66205 | Completed |
| Local Institution - 0165 | Wichita | Kansas | 67214-3728 | Completed |
| University of Louisville-James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | Recruiting |
| Local Institution - 0092 | Baltimore | Maryland | 21287 | Completed |
| Local Institution - 0039 | Boston | Massachusetts | 02114 | Completed |
| Dana_Farber Cancer Institute (DFCI) | Boston | Massachusetts | 02215 | Recruiting |
| Local Institution - 0081 | Boston | Massachusetts | 02215 | Withdrawn |
| Local Institution - 0143 | Ann Arbor | Michigan | 48109-5008 | Completed |
| Local Institution - 0100 | Minneapolis | Minnesota | 55407-3723 | Completed |
| Local Institution | St Louis | Missouri | 63110 | Withdrawn |
| Local Institution - 0205 | Omaha | Nebraska | 68130 | Completed |
| Local Institution - 0014 | Lebanon | New Hampshire | 03756 | Completed |
| Local Institution | Albuquerque | New Mexico | 87131 | Withdrawn |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | Recruiting |
| NYU Langone Hematology Oncology Associates-Mineola | Mineola | New York | 11501 | Recruiting |
| Local Institution | New York | New York | 10016 | Withdrawn |
| Local Institution - 0185 | New York | New York | 10065 | Completed |
| Local Institution - 0202 | New York | New York | 10065 | Withdrawn |
| Local Institution | New York | New York | 10065 | Withdrawn |
| Local Institution - 0204 | Charlotte | North Carolina | 28204 | Completed |
| Local Institution - 0016 | Durham | North Carolina | 27705 | Completed |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | Recruiting |
| Local Institution - 0408 | Cincinnati | Ohio | 45267 | Active, not recruiting |
| Local Institution | Cleveland | Ohio | 44106 | Withdrawn |
| The Ohio University | Columbus | Ohio | 43210 | Recruiting |
| Local Institution - 0246 | Tulsa | Oklahoma | 74146 | Withdrawn |
| Local Institution - 0037 | Allentown | Pennsylvania | 18103 | Completed |
| Local Institution - 0054 | Easton | Pennsylvania | 18045 | Completed |
| Lancaster General Health | Lancaster | Pennsylvania | 17601 | Recruiting |
| Allegheny Valley Hospital | Natrona Heights | Pennsylvania | 15065 | Withdrawn |
| Local Institution | Philadelphia | Pennsylvania | 19104 | Withdrawn |
| Local Institution - 0162 | Philadelphia | Pennsylvania | 19111 | Withdrawn |
| Local Institution - 0110 | Pittsburgh | Pennsylvania | 15213 | Completed |
| Local Institution - 0228 | Charleston | South Carolina | 29414 | Completed |
| Local Institution | Greenville | South Carolina | 29615 | Withdrawn |
| Local Institution | Chattanooga | Tennessee | 37404 | Withdrawn |
| Tennesse Oncology | Nashville | Tennessee | 37203 | Recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Withdrawn |
| Local Institution | Dallas | Texas | 75390 | Withdrawn |
| Local Institution - 0364 | Houston | Texas | 77030-4000 | Withdrawn |
| Local Institution - 0055 | Salt Lake City | Utah | 84112-5550 | Completed |
| Local Institution | Charlottesville | Virginia | 22908 | Withdrawn |
| Public Hospital of King County District 1 Valley Medical Center | Renton | Washington | 98055 | Withdrawn |
| Local Institution - 0065 | Madison | Wisconsin | 53792 | Completed |
| Local Institution - 0124 | Madison | Wisconsin | 53792 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 340 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03899155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03899155 live on ClinicalTrials.gov.